Queensland Institute of Medical Research scientist David Harrich will begin animal trials this year, with experiments in humans are still five years away. Associate Professor Harrich has manipulated an HIV protein involved in gene expression, known as Tat, and turned it into a weapon against the virus.
- Published
- 16 January 2013
- From
-
news.com.au
The presence of cytomegalovirus (CMV) in
blood and semen is associated with higher levels of HIV DNA in blood,
investigators from the United States report in the
- Published
- 16 January 2013
- By
- Michael Carter
Scientists have identified how HIV, the virus that causes AIDS, enters the cells of the immune system enabling it to be dispersed throughout an organism.
- Published
- 19 December 2012
- From
-
Science Daily
Breakthrough drugs help people to live longer with HIV, but more research is needed for an actual cure. One challenge involves eradicating the virus when it is latent in the body. Research in the December 2012 issue of the Journal of Leukocyte Biology suggests the cancer drug, JQ1, may be useful in purging latent HIV infection by activating the virus in the presence of potent therapy -- essentially a dead end for the virus.
- Published
- 29 November 2012
- From
-
Eurekalert Medicine & Health
When the history of HIV/AIDS is at last written, what will the final chapter look like? With contributions from: Timothy Ray Brown, Jeanne White Ginder, Cleve Jones, Barbara Lee, Mark Dybul, Paul Farmer, Robert Gallo, Mervyn Silverman, Diane Havlir, Scott Wiener, LZ Granderson, Hank Plante, Eduardo Xol, and Neil Giuliano.
- Published
- 28 November 2012
- From
-
San Francisco AIDS Foundation
A newly discovered gene that is essential for embryo survival could also hold the key to treating and potentially controlling chronic infections such as HIV, hepatitis and tuberculosis. The gene, called Arih2, is fundamental to the function of the immune system - making critical decisions about whether to switch on the immune response to an infection.
- Published
- 27 November 2012
- From
- Science Daily
Adding pegylated interferon alfa to antiretroviral therapy (ART) for HIV may help some people control viral replication when they interrupt treatment, according to a small study reported at this year's Conference on Retroviruses and Opportunistic Infections (CROI 2012) and published in the October 26, 2012, advance online edition of the Journal of Infectious Diseases.
- Published
- 12 November 2012
- From
-
HIVandHepatitis.com
Short treatment interruptions of HIV antiretroviral regimens are both safe and well-tolerated, which is good news for scientists pursuing functional cures.
- Published
- 05 November 2012
- From
-
AIDSMeds
New research has disocvered how the HIV virus targets memory T-cells or "veterans" instead of naive "virgin" T-cells. This could potentially change how drugs are used to halt the virus. This research finds that HIV exploits the fact that memory T-cells are more mobile; it uses the cytoskeleton, the internal structure of the cell, as a "conveyor belt" to carry it deep within the cell and to the nucleus. The researchers are now looking at whether drugs that reduce cancer cell motility could reduce the "attractiveness" of T-memory cells to HIV.
- Published
- 25 October 2012
- From
-
Medical News Today
In monkeys and humans with AIDS, damage to the gastrointestinal tract is common, contributing to activation of the immune system, progressive immune deficiency, and ultimately advanced AIDS.
- Published
- 15 October 2012
- From
- HIV / AIDS News From Medical News Today
Get set for HIV treatmentA tool to help you decide whether you are ready to start taking HIV treatment.
HIV, GPs & other primary careThis booklet explains the services GPs offer, how this fits with HIV specialist care, and how to make the most of primary care services.
Treatment as prevention – free webinar 20 March 2013As
part of its European HIV prevention work, NAM is collaborating...
Microbicides research – free webinar 22 February 2013As
part of its European HIV prevention work, NAM is collaborating...
HIV treatment update – Winter 2013 21 February 2013The new edition of HIV treatment update (HTU) is on...